Walgreens and CVS Will Carry Abortion Pills Soon—Here’s What You Should Know

Walgreens and CVS have officially received FDA certification to fulfill prescriptions for mifepristone, the first of two drugs needed for a medication abortion. Currently, the use of abortion pills accounts for more than half of all abortions in the United States.

Having the option to pick up mifepristone at these major pharmacies “could be a game-changer in post-Roe America, where 14 states have now banned abortion almost entirely,” Rabia Muqaddam, a senior staff attorney at the Center for Reproductive Rights, tells SELF.

In the past, people who needed abortion care had to get mifepristone from certain mail-order pharmacies or certified clinics, medical offices, or hospitals. However, the FDA made a big regulatory change in January 2023: Pharmacies that agree to follow certain criteria are now allowed to dispense mifepristone in stores and by mail order.

Mifepristone is an oral drug that blocks a hormone called progesterone, which the body needs to continue a pregnancy. It’s usually followed by misoprostol, a drug that causes the cervix to soften and dilate to help the body expel the pregnancy. (Both CVS and Walgreens already dispense misoprostol.)

Abortion care is, sadly, still a hot-button topic—so this win for reproductive rights is bound to be a little sticky at first. Case in point: Certified medical providers will tell their patients which Walgreens locations to go to for their prescriptions, but this information won’t be easy to find on your own. “In the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing [mifepristone],” Walgreens states on its site. (It’s unclear whether CVS will take the same approach.)

There are other restrictions to be aware of too. Here’s what we know about how this will all shake out, plus what this means for the future of abortion care.

How do you get mifepristone at Walgreens and CVS?

Mifepristone will not be available over the counter, so you’ll still need to see a health care provider (either in-person or via telehealth) to receive a prescription for the medication. From there, your doctor should direct you to a Walgreens or CVS near you that will give you the medication. (Not sure where to go for an Rx? Search for clinics near you through Planned Parenthood here.)

Which states will offer mifepristone at Walgreens and CVS—and when will it be available?

The FDA’s regulatory change doesn’t override state laws. So if your state bans or severely limits abortion care, mifepristone won’t be available at your local Walgreens or CVS.

Both companies are working on gradual rollouts, so not all eligible pharmacies will be ready right away. In fact, CVS isn’t planning to have this service available anywhere for a few weeks. “We’re working with manufacturers and suppliers to secure the medication and are not yet dispensing it in any of our pharmacies,” a CVS spokesperson tells SELF via email. CVS plans to start filling mifepristone prescriptions in Massachusetts and Rhode Island in “the weeks ahead,” and will then expand to additional states, where it’s allowed by law, on a “rolling basis.”

Walgreens will also have a “phased rollout in select locations,” but prescriptions should be available at select locations “within a week.” It plans to start dispensing mifepristone in select locations in New York, Pennsylvania, Massachusetts, California, and Illinois first.

Why does this change matter? Experts say it’s all about access.

According to Jessica Shepherd, MD, a board-certified ob-gyn in Texas, increased access to mifepristone is a “particularly important” move for reproductive justice. Not only will it help more people safely end their pregnancies—for whatever reason they choose to have abortions—but it’s also a solid step in addressing the rising maternal mortality rates in the US, which disproportionately impacts Black women and people who live in low-income areas.

“Maternal mortality rates continue to rise and women do not have more access [to quality health care], but less,” Dr. Shepherd tells SELF. Abortion is health care, and delaying one can have devastating effects on miscarriage care and ectopic pregnancy treatments, to name just a couple of examples. Having mifepristone available at CVS and Walgreens is simply one more option for doctors who are often caught in the political crossfire: “This will enable providers the ability to treat some patients without as many obstacles,” Dr. Shepherd says.

Again, the change unfortunately won’t help people in states where there are near or total bans—meaning it’s more important than ever to vote. The fight for abortion care is far from over: Ally Boguhn, the communications director for Reproductive Freedom for All, tells SELF that the Supreme Court will hear a case that could have an impact on mifepristone access—even in states where abortion is legal—in just a few weeks, with a decision expected in June. “Abortion access has already been devastated by the Court overturning Roe v. Wade,” Boguhn says, “and this case could further decimate people’s freedom to make the personal medical decisions that are best for themselves and their families.”

Related:

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
경찰, ‘공금 115억 횡령 혐의’ 공무원 구속영장 신청 thumbnail

경찰, ‘공금 115억 횡령 혐의’ 공무원 구속영장 신청

A씨 고발장 접수 하루만에 자택 주차장서 체포 경찰이 100억원이 넘는 공금을 빼돌린 혐의로 긴급체포된 한 공무원에 대해 구속영장을 신청했다. 경찰은 지난 24일 40대 남성 A씨를 특정경제범죄 가중처벌법상 업무상 횡령 혐의로 긴급체포한 뒤 조사를 벌여 25일 구속영장을 신청했다. 당시 주무관이었던 A씨는 2019년 12월께부터 지난해 2월까지 자원순환센터의 건립자금 가운데 115억원을 횡령한 혐의를 받고 있다. 횡령금 가운데 38억원만…
Read More
The Confusing Fate of the Abortion Pill thumbnail

The Confusing Fate of the Abortion Pill

KFF Health News’ ‘What the Health?’Episode Title: The Confusing Fate of the Abortion PillEpisode Number: 293Published: April 13, 2023 [Editor’s note: This transcript, generated using transcription software, has been edited for style and clarity.] Julie Rovner: Hello and welcome back to “What the Health?” I’m Julie Rovner, chief Washington correspondent at KFF Health News. And
Read More
Index Of News
Total
0
Share